Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318690 | SCV000849979 | pathogenic | Inborn genetic diseases | 2016-05-03 | criteria provided, single submitter | clinical testing | The c.469delC pathogenic mutation, located in coding exon 6 of the TCF4 gene, results from a deletion of one nucleotide at position 469, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |
Eurofins Ntd Llc |
RCV000734489 | SCV000862637 | pathogenic | not provided | 2018-08-16 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990105 | SCV001140902 | pathogenic | Pitt-Hopkins syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing |